期刊文献+

细胞周期蛋白D_1在阿霉素诱导大鼠慢性进行性肾脏损害模型中的表达及罗格列酮干预效应 被引量:2

The expression of cyclin D1 in renal tissue of rats with adriamycin induced chronic kidney disease and the effects of rosiglitazone intervention
下载PDF
导出
摘要 目的研究细胞周期蛋白D1(cyclin D1)在阿霉素诱导大鼠慢性进行性肾脏损害模型中的表达,以及罗格列酮(RSG)干预对其表达的影响,探讨RSG肾脏保护效应的可能机制。方法 45只2月龄SD大鼠随机分成对照组、肾损害组、RSG干预组。肾损害组和RSG干预组从尾静脉注射阿霉素(ADR)6 mg/kg建立肾病模型,对照组注射生理盐水。2周后,RSG干预组给予RSG(4 mg/kg)灌胃,对照组和肾损害组给予等量蒸馏水灌胃。模型建立当天、第14天、70天分别收集24 h尿测尿蛋白;模型建立第70天取血测肝肾功能、电解质、血糖,苏木素-伊红染色观察肾脏病理学改变,免疫组化及RT-PCR测定cyclin D1表达。结果 RSG干预组24 h尿蛋白定量、血清白蛋白、三酰甘油、胆固醇水平,系膜细胞和成纤维细胞cyclin D1蛋白及mRNA表达量与肾损害组比较,差异均有统计学意义(P均<0.05)。病理学观察,RSG干预组大鼠的肾脏损害较肾损害组轻。结论 RSG可减轻阿霉素诱导的肾损害。RSG下调肾脏系膜细胞及成纤维细胞cyclin D1表达可能是其肾保护机制之一。 objective To detect the expression of eyclin Dl in renal tissue of rats with adriamycin (ADR) induced chronic kidney disease (CKD) and the effects of rosiglitazone (RSG) intervention, to explore the possible mechanisms of renoprotective effects of RSG. Methods Forty-five SD rats, 2 months old, were randomly divided into three groups, control group, model group, and RSG intervention group. ADR (6 mg/kg) was injected through the tail vein of rats in model group and RSG intervention group for production of CKD animal model. The normal saline was injected in control group. After two weeks, RSG intervention group received RSG (4 mg/kg) via nasogastric garage; control group and model group received same amount of distill water. The 24 hours urine was collected for measurement of urine protein at ADR injection, and after injection 14 and 70 days. After ADR injection 70 days, the blood was collected for detecting liver and kidney function, electrolytes, and glucose. The pathological change of kidneys was observed. The expression of cyclin D1 was examined with immunohistochemistry and RT-PCR. Results Compare with model groups, 24 hour urinary protein .excretion, the level of serum albumin, triglyceride and cholesterol, and the expression of cyclin D1 in mesangial cells and fibroblastsis were significantly different in RSG intervention group (all P 〈 0.05). Pathological damage was slighter in RSG intervention group than that in model group. Conclusions RSG can reduced kidney damage induced by ADR. RSG intervention reduced the expression of eyclin D1 in mesangial cells and fibroblasts may be one of the mechanisms of renal protection by RSG.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2012年第1期70-74,共5页 Journal of Clinical Pediatrics
关键词 慢性肾脏损害 阿霉素 细胞周期蛋白 罗格列酮 大鼠 chronic kidney disease adriamycin cyclin D1 rosiglitazone rat
  • 相关文献

参考文献12

  • 1Liu Y.Renal fibrosis:new insights into the pathogenesis and therapeutics[J].Kidney Int,2006,69(2):213-217.
  • 2Eddy AA.Molecular basis of renal fibrosis[J].Pediatr Nephrol,2000,15(3):290-301.
  • 3Fogo AB.Mechanisms of progression of chronic kidney disease[J].Pediatr Nephrol,2007,22(12):2011-2022.
  • 4Wolf G,Ziyadeh F.Molecular mechanisms of diabetic renal hypertrophy[J].Kidney Int,1999,56(2):393-405.
  • 5Flaquer M,Lloberas N,Franquesa M,et al.The combina-tion of sirolimus and rosiglitazone produces a renoprotec-tive effect on diabetic kidney disease in rats[J].Life Sci,2010,87(5-6):147-153.
  • 6许涛,吕磊,钱琛,王迎新.大鼠阿霉素肾病的病理学观察[J].中国临床药理学与治疗学,2001,6(1):43-45. 被引量:18
  • 7Genolet R,Wahli W,Michalik L,et al.PPARs as drug targets to modulate inflammatory responses[J].Curt Drug Targets Inflamm Allergy,2004,3(4):361-375.
  • 8Qin C,Burghardt R,Smith R,et al.Pero-xisome prolife-rator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells[J].Cancer Res,2003,63(5):958-964.
  • 9Sato K,Sugawara A,Kudo M,et al.Expression of peroxi-some proliferator-activated receptor isoform proteins in the rat kidney[J].Hypertens Res,2004,27(6):417-425.
  • 10Qiu LQ,Sinniah R,Hsu SI,et al.Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy[J].Lab Invest,2004,84(9):1112-1125.

二级参考文献4

共引文献17

同被引文献23

  • 1BHAISSANT 0, FOUFELLE F, SCOTTO C, et al. Differentialexpression of peroxisome proliferator - activated receptors(PPARs) : tissue distribution of PPAH - alpha, -beta,and -gamnm in the adult rat[J]. Endcxtrinolog)-, 1996, 137(1): 354-366.
  • 2SKIVASTAVA HA. Evaluation of anti-atherosclerotic activities ofPPAK - a, PPAR - *y and LXR agonists in hyperlipidemicathemsclerosis - susceptible F (1 )B hamsters [J ]. Atherosclerosis,2011, 214(1): 86-93.
  • 3KAMANNA VS, BASSA BV, GANJI SH, et d. Bioactivelysophospholipids and mesangial cell intracellular signalingpathways : role in the pathobiolog)1 of kidney disease [J]. I iistolHistopathol, 2005, 20(2): 603-613.
  • 4KAWA1 T, MASAKI T, DOI S,et al. PPAR - gamma agonistattenuates renal interstitial fibrosis and inflanjmalion throughreduction of T(;F-hatalJl. Lab Invest, 2009, 89( 1) : 47-58.
  • 5DAI B, LIU YW, MK1 CL, et id. Hosigiitazone attenuatesdevelopment of ploycystic kidney disease and prolongs survivalin Han: SPHD rats[Jj. Clin SH(LomU’ 2010,丨 19(8): 323-333.
  • 6LAI KN, CHAN LY, GUO H, et al. Additive effect of PPAR--yagonist and AHB in treatment of experimental IgA nephropathy[j|. Pediatr Nephrol, 2011, 26(2): 257-266.
  • 7FIORENTINO M, ZADRA G,PALESCANDOIX) E, et ai.Overexpression of fatty acid synthase is associated withpalmitoyation of Wntl and cytoplasmic stabilization of beta -ratenin in prostate oancer[J]. Lab Invest, 2008, 88( 12) : 1340-1348.
  • 8MarDONAIi) BT, TAMAI K, HE X. Wnt/I>eta - cateninsignaling: components, mechanisms, and diseases[Jj. Dev Cell,2009, 17(1): 9-26.
  • 9GAO J, ZHU J, LI HY, et al. Small interfering RNA targeting integrin- linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells[J]. Int J Biochem Cell Biol, 2011, 43(9): 1294-1297.
  • 10ROONEY N, STREULI CH. How integrins control mammary epithelial differentiation: a possible role for the ILK- PINCH- Parvin complex[J]. FEBS Lett, 2011, 585( 11 ) : 1663-1672.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部